|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/24/23 CollPlant Biotechnologies Ltd. 6-K 6/30/23 47:2.9M EdgarAgents LLC/FA |
Document/Exhibit Description Pages Size
1: 6-K Report of Foreign Private Issuer HTML 23K
2: EX-99.1 Press Release, Dated August 24, 2023 HTML 150K
3: EX-99.2 Condensed Consolidated Interim Financial HTML 354K
Statements (Unaudited) as of June 30, 2023
4: EX-99.3 Operating and Financial Review and Prospects as of HTML 95K
June 30, 2023
10: R1 Document And Entity Information HTML 32K
11: R2 Condensed Consolidated Balance Sheets HTML 125K
12: R3 Condensed Consolidated Balance Sheets HTML 26K
(Parentheticals)
13: R4 Condensed Consolidated Statements of Operations HTML 80K
(Unaudited)
14: R5 Condensed Consolidated Statements Shareholders? HTML 62K
Equity (Unaudited)
15: R6 Condensed Consolidated Statements of Cash Flows HTML 111K
(Unaudited)
16: R7 Nature of Operations HTML 20K
17: R8 Significant Accounting Policies HTML 34K
18: R9 Inventory HTML 22K
19: R10 Share Capital HTML 48K
20: R11 Development, Exclusivity and Option Products HTML 20K
Agreement
21: R12 Supplementary Financial Statement Information HTML 51K
22: R13 Subsequent Events HTML 20K
23: R14 Accounting Policies, by Policy (Policies) HTML 44K
24: R15 Significant Accounting Policies (Tables) HTML 27K
25: R16 Inventory (Tables) HTML 21K
26: R17 Share Capital (Tables) HTML 45K
27: R18 Supplementary Financial Statement Information HTML 52K
(Tables)
28: R19 Significant Accounting Policies (Details) HTML 18K
29: R20 Significant Accounting Policies (Details) - HTML 51K
Schedule of Earnings Per Share Basic and Diluted
30: R21 Inventory (Details) HTML 18K
31: R22 Inventory (Details) - Schedule of Inventories HTML 22K
32: R23 Share Capital (Details) HTML 28K
33: R24 Share Capital (Details) - Schedule of Shares HTML 33K
Issued Granted Options
34: R25 Share Capital (Details) - Schedule of Fair Value HTML 34K
of Options Granted to Employees on the Date of
Grant Was Computed Using athe Black-Scholes Model
35: R26 Share Capital (Details) - Schedule of Summarizes HTML 47K
the Number of Options Granted to Employees Under
the Option Plan
36: R27 Share Capital (Details) - Schedule of Share-Based HTML 26K
Compensation
37: R28 Development, Exclusivity and Option Products HTML 28K
Agreement (Details)
38: R29 Supplementary Financial Statement Information HTML 21K
(Details)
39: R30 Supplementary Financial Statement Information HTML 29K
(Details) - Schedule of Disaggregated Revenues
40: R31 Supplementary Financial Statement Information HTML 31K
(Details) - Schedule of Revenues by Geographical
Area
41: R32 Supplementary Financial Statement Information HTML 28K
(Details) - Schedule of Revenue by Major Customers
42: R33 Subsequent Events (Details) HTML 27K
45: XML IDEA XML File -- Filing Summary XML 82K
43: XML XBRL Instance -- ea183936-6k_collplantbio_htm XML 560K
44: EXCEL IDEA Workbook of Financial Report Info XLSX 60K
6: EX-101.CAL XBRL Calculations -- clgn-20230630_cal XML 82K
7: EX-101.DEF XBRL Definitions -- clgn-20230630_def XML 329K
8: EX-101.LAB XBRL Labels -- clgn-20230630_lab XML 690K
9: EX-101.PRE XBRL Presentations -- clgn-20230630_pre XML 332K
5: EX-101.SCH XBRL Schema -- clgn-20230630 XSD 113K
46: JSON XBRL Instance as JSON Data -- MetaLinks 228± 329K
47: ZIP XBRL Zipped Folder -- 0001213900-23-070415-xbrl Zip 138K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Form i 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of August i 2023
Commission File Number i 001-38370
i CollPlant Biotechnologies Ltd.
(Exact name of registrant as specified in its charter)
4 Oppenheimer St, Weizmann Science Park
Rehovot 7670104, Israel
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
This Form 6-K, the text under the heading “Second Quarter 2023 Financial Results”, the accompanying consolidated financial statements and “Forward Looking Statements” of the press release attached to this Form 6-K as Exhibit 99.1, Exhibit 99.2 and Exhibit 99.3 are hereby incorporated by reference into the registrant’s Registration Statements on Form S-8 (File No. 333-229163, 333-248479, 333-263842 and 333-271320) and Form F-3 (File No. 333-228054, 333-238731 and 333-269087), to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.
On August 24, 2023, CollPlant Biotechnologies Ltd. (the “Company”) issued a press release entitled “CollPlant Biotechnologies Provides Business Updates and Second Quarter 2023 Financial Results”. In addition, on the same day, the Company issued condensed consolidated interim financial statements (unaudited) as of June 30, 2023 together with the Company’s Operating and Financial Review and Prospects for the same period.
Attached hereto and incorporated by reference herein are the following exhibits:
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| COLLPLANT BIOTECHNOLOGIES LTD. | |||
| Date: August 24, 2023 | By: | /s/ Eran Rotem | |
| Name: | Eran Rotem | ||
| Title: | Deputy CEO and Chief Financial Officer | ||
2
| This ‘6-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 8/24/23 | None on these Dates | ||
| For Period end: | 6/30/23 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/18/23 CollPlant Biotechnologies Ltd. S-8 4/18/23 4:201K EdgarAgents LLC/FA 12/30/22 CollPlant Biotechnologies Ltd. F-3 6:415K EdgarAgents LLC/FA 3/25/22 CollPlant Biotechnologies Ltd. S-8 3/25/22 4:81K EdgarAgents LLC/FA 8/28/20 CollPlant Biotechnologies Ltd. S-8 8/28/20 3:116K EdgarAgents LLC/FA 5/27/20 CollPlant Biotechnologies Ltd. F-3 3:479K EdgarAgents LLC/FA 4/08/19 CollPlant Biotechnologies Ltd. F-3/A 3:425K EdgarAgents LLC/FA 1/08/19 CollPlant Biotechnologies Ltd. S-8 1/08/19 3:101K EdgarAgents LLC/FA |